Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
000338 000063 000157 600998 IT Small Growth Market Drivers Healthcare Funds 
United States  USA  |  Optimize Portfolios


Processing
Collecting data for 300009

Anhui quote and profile

 
 Companies |  Insiders  | Dashboard  
     
19.5
  
STOCK
(0.28)  Macroaxis: -1.42 Down   1.42%  
Year To Date
9.214.97
Trading Day 
19.2819.95
May 18 2013 

Diversification Suggestion

Use Anhui to protect against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly
Analyze Anhui Anke Biotechno Trend or Check current 30 days Anhui correlation with market (Shanghai)
1 Month Beta -0.96  
Highest Price:  
Lowest Price:  
20.3  
18.85  
May 03 2013 
April 26 2013 
Anhui Anke Biotechnology Group llmost one BetaAnhui Anke Biotechno Beta Legend
300009 China Shenzhen #CNE100000GY2CN
Anhui Anke Biotechnology Group
Currency: CNY - Chinese Yuan
Traded on Shenzhen Stock Exchange
    
Number of Employees16
 China Shangh   1.38 % Macroaxis: change 1.38 Moved Up  
 
 thisRed 300009 300009.SZ agains markets  1.42 % Macroaxis: change 1.42 Moved Down  
 
Compare to Competition Get Alpha   Get Advice
    
Lihua Song  Chairman
Chairman of the Board, General Manager
Mr. Song Lihua is Chairman of the Board and General Manager in Anhui Anke Biotechnology Co Ltd. He holds a Master degree. He is Parttime Professor in University of Science and Technology of China, Anhui Medical Universi...
    

Anhui correlation with market

Very good diversification
Overlapping area represents amount of risk that can be diversified away by holding Anhui Anke Biotechnology Group and equity matching 000001 index in the same portfolio

Anhui Performance

Price Growth (%)  
Anhui   Market   
 

Anhui 30-Days Risk-Return Take

If you would invest  1,930  in Anhui Anke Biotechnology Group on April 18, 2013 and sell it today you would earn a total of  28.00  from holding Anhui Anke Biotechnology Group or generate 1.45% return on investment over 30 days. Anhui Anke Biotechnology Group is generating 0.17% of daily returns and assumes 2.92% volatility on return distribution over the 30 days horizon. Simply put, 38% of equities are less volatile than Anhui Anke Biotechnology Group and 91% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
Daily Expected Return (%)
 
Risk [Daily Volatility] (%)
Assuming 30 trading days horizon, Anhui Anke Biotechnology Group is expected to generate 1.65 times less return on investment than the market. In addition to that, the company is 2.7 times more volatile than its market benchmark. It trades about 0.06 of its total potential returns per unit of risk. The Shanghai is currently generating roughly 0.26 per unit of volatility.
Past Market
Over 30
Days
3
Out Of
100
 
Chance of
Less
Than
34 %
 
Follow Anhui with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Anhui to your reader
 

Anhui Research Report

Anhui vs. Weichai

Correlation analysis and fundamentals comparison between Anhui Anke Biotechno and Weichai Power

Anhui vs Competition

Anhui vs. Weichai Power Co Ltd
Anhui vs. Zte Corporation
Anhui vs. Zoomlion Heavy Industry Science and Technology Co Ltd
Anhui vs. Jointown Pharmaceutical Group Co Ltd
Anhui vs. Chongqing Tongjunge Co Ltd
Anhui vs. Beijing Yanjing Brewery Co Ltd
Anhui vs. Huatai Securities Co Ltd
Anhui vs. GUANGZHOU AUTOMOBILE GROUP CNY1
Anhui vs. Xian Aircraft International Corporation
Anhui vs. Shandong Chenming Paper Holdings Limited

Anhui May 18 2013 Opportunity Range

Downside Deviation3.22
Information Ratio(0.0093)
Maximum Drawdown9.06
Value At Risk(5.01)
Potential Upside5.84

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium